City of Hope, Duarte
University of California, Los Angeles (UCLA) - Medical Center, Los Angeles
University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, San Francisco

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07226843

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

Research Site, Clovis
Research Site, Los Alamitos
Research Site, San Diego
at 1 pa

Nagre-recruitPhase 3

Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06549595

NEO100 and High-Grade Meningioma

University of Southern California, Los Angeles
Sutter Health Research Institute, San Francisco
Saint John Cancer Institute, Santa Monica

Nagre-recruitPhase 2

Edad 12 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT05023018

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

David Geffen School of Medicine at UCLA, Los Angeles

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06091254

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Research Site, Duarte

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06526793

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

City of Hope Comprehensive Cancer Center, Duarte
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
UC San Diego Moores Cancer Center, La Jolla
at 2 pa

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06860594

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
City of Hope Comprehensive Cancer Center, Duarte
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
at 2 pa

Nagre-recruitPhase 3

Edad 12 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07215910

A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234

Research Site, Rialto

Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo

Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07546760

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

University of California San Diego, La Jolla
University of California, Los Angeles, Los Angeles
Hoag Memorial Hospital Presbyterian, Newport Beach
at 2 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519

A Study of ARC-02 in B-cell NHL

Start Cala, Los Angeles

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT07691606

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

University of California-Irvine Medical Center, Irvine
Cedars-Sinai Medical Center, Los Angeles
University of California, Los Angeles (UCLA) Medical Center, Los Angeles
at 1 pa

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses

Community Health Project Los Angeles (CHPLA), Los Angeles

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT07631598

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

David Geffen School of Medicine at UCLA, Los Angeles

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT06149286

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

Stanford University, Palo Alto

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT06340737

Interventions in Mathematics and Cognitive Skills

Stanford Cognitive and Systems Neuroscience Laboratory, Palo Alto

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Edad 6 hanggang 12 · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05201534

STimulation to Activate RespIration

University of California San Diego, La Jolla

Nagre-recruit

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06832306

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

City of Hope, Duarte
Valkyrie Clinical Trials, Los Angeles

Nagre-recruitPhase 1/2

Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06533579

A Long-term Extension Study of PCI-32765 (Ibrutinib)

St. Joseph Hospital Center for Cancer Prevention and Treatment, Orange

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT01804686

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

START Los Angele, Los Angeles

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT07424833

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

City of Hope, Duarte

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 24, 2026 · NCT07121946

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

City of Hope, Duarte
University of California, San Francisco, San Francisco

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT05131022

Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma

City of Hope Medical Center, Duarte

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT06815029

Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

University of California Davis Comprehensive Cancer Center, Sacramento

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT04587687

Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

University of California, San Francisco, San Francisco

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT04545762

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

City of Hope Comprehensive Cancer Center, Duarte
UCSF Helen Diller Medical Center at Parnassus Heights, San Francisco

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update May 20, 2026 · NCT06911502

Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

City of Hope Medical Center, Duarte

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 20, 2026 · NCT06859008

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

City of Hope, Duarte
Los Angeles Cancer Network, Los Angeles
UCLA Medical Center of Hematology/Oncology, Los Angeles
at 1 pa

Nagre-recruitPhase 1/2

Edad 12 hanggang 95 · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT04329728

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

City of Hope, Duarte

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 20, 2026 · NCT04830137

Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy

Stanford, Stanford

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT06510361

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

UC Irvine Health, Orange

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Dis 10, 2025 · NCT05602363

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Duarte
Massive Bio SYNERGY-AI site, Irvine
Massive Bio SYNERGY-AI site, La Jolla
at 3 pa

Nagre-recruitObservasyonal na pag-aaral

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy

Stanford Cancer Center, Palo Alto

Nagre-recruitObservasyonal na pag-aaral

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 22, 2024 · NCT05255354

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.